Skip to main content
Signal8

Hughes Douglas J.

SEC insider (Form 3/4/5 filer). CIK 0001710863. Director at Immunovant, Inc. (IMVT). 5 reported Form 4/5 transactions since Sep 2024; latest on Apr 7, 2026. Located in DURHAM, NC.

Companies Hughes Douglas J. has filed insider reports for

  • Immunovant, Inc. (IMVT): Director
Hughes Douglas J. profile photo

Hughes Douglas J.

CIK: 0001710863

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (60.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Immunovant, Inc. logo
IMVT

Immunovant, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Apr 7, 2026
    Award
    Direct
    13.9K shares-
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Dec 1, 2025
    Sale
    Direct
    13.1K shares at avg. $23.14$303K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Dec 1, 2025
    Sale
    Direct
    1.9K shares at avg. $23.96$46K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Apr 1, 2025
    Award
    Direct
    16.2K shares-
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Dec 2, 2024
    Sale
    Direct
    5.4K shares at avg. $28.54$155K

1-5 of 5